期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 54, 期 16, 页码 5796-5810出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm200511x
关键词
-
资金
- Chinese National Science Fund [30973627]
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- Natural Science Foundation of China for Distinguished Young Scholars [30725046]
- National Science & Technology Major Project Key New Drug Creation and Manufacturing Program [2009ZX09301-001, 2009ZX09103-045]
- Program of Shanghai Subject Chief Scientist [10XD1405100]
- Science and Technology Planning Project of Shandong Province, China [2010GSF10216]
- program for Changjiang Scholars and Innovative Research Team in University [IRT0944]
Fifteen citrinin derivatives (1-4,6-16), including two unprecedented citrinin timers tricitrinols A (3) and B (4), were isolated from Penicillium citrinum HGY1-5. The six-membered ring A system is essential for the cytotoxicity of active dimers (1, 2, and 5) and trimers (3 and 4). Tricitrinol B (4) showed extensive cytotoxicity in 17 tumor cells with comparable low-micromolar IC50 values (1-10 mu M) and potential antimultidrug resistance capabilities. Tricitrinol B (4) induced cell apoptosis in HL60 and HCT116 cells via mainly extrinsic pathways and G2/M arrest. Further antitumor mechanism study and computational docking analysis indicated that tricitrinol B (4) works as an intercalating topoisomerase II alpha (topo II alpha) poison, which inhibits the enzyme activity of topo II alpha by interfering predominantly with the topo II alpha-mediated poststrand-passage deavage/religation equilibrium over with the prestrand-passage one and induced DNA damage. Tricitrinol B (4) represents a novel class of topo II alpha-inhibitory skeletons for developing new chemotherapeutic agents.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据